Website Header with Language Selector and Dropdowns
Image

Cidofovir Impurity 3


Catalog Number: CL-CIO-08
CAS No.: NA
Mol.F: C32H38N3O6P
Mol.W: 591.6
Inv. Status: Custom Synthesis

Chemical Name: Ethyl propyl (((1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-(trityloxy)propan-2-yl)oxy)methyl)phosphonate.

Country of Origin: India

Product Category: Cidofovir Impurities


Cidofovir Impurity 3 is identified by CAS No. NA and is chemically known as Ethyl propyl (((1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-(trityloxy)propan-2-yl)oxy)methyl)phosphonate.

Cidofovir Impurity 3 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Cidofovir.

Page Keywords: Buy Cidofovir Impurity 3 | Purchase Cidofovir Impurity 3 | Cidofovir Impurity 3 suppliers | Cidofovir Impurity 3 manufacturers | Cidofovir Impurity 3 price | Cidofovir Impurity 3 Importer | Cidofovir Impurity 3 Exporter

Enquiry Now

Personal Details

Product Details

Related Products

CAT No: CL-CIO-07
CAS No: NA
Mol Wt: 342.1
Mol F: C8H13BrN3O5P
Inv. Status: Custom Synthesis
CAT No: CL-CIO-01
CAS No: 149394-66-1
Mol Wt: 279.2 : 2(18.0)
Mol F: C8H14N3O6P : 2(H2O)
Inv. Status: Custom Synthesis
CAT No: CL-CIO-05
CAS No: NA
Mol Wt: 185.2 : 36.5
Mol F: C7H11N3O3 : HCl
Inv. Status: Custom Synthesis
CAT No: CL-CIO-06
CAS No: 133868-60-7
Mol Wt: 279.2
Mol F: C8H14N3O6P
Inv. Status: Custom Synthesis
CAT No: CL-CIO-09
CAS No: NA
Mol Wt: 336.3 : 36.5
Mol F: C12H23N3O6P : HCl
Inv. Status: Custom Synthesis
CAT No: CL-CIO-04
CAS No: 116558-96-4
Mol Wt: 280.2
Mol F: C8H13N2O7P
Inv. Status: Custom Synthesis
CAT No: CL-CIO-02
CAS No: 1312776-50-3
Mol Wt: 307.2
Mol F: C10H18N3O6P
Inv. Status: Custom Synthesis
CAT No: CL-CIO-03
CAS No: 120362-35-8
Mol Wt: 335.3
Mol F: C12H22N3O6P
Inv. Status: Custom Synthesis
Subscribe for news letter:
  

© Cleanchem Laboratories LLP. All Rights Reserved.